Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders
- 30 June 2003
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 38 (6), 818-826
- https://doi.org/10.1016/s0168-8278(03)00076-x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Long-term follow-up of patients with chronic hepatitis B treated with interferon alfaGastroenterology, 1997
- Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis BNew England Journal of Medicine, 1996
- Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter studyJournal of Hepatology, 1994
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993
- Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liverGastroenterology, 1992
- Natural history and prognostic factors for chronic hepatitis type B.Gut, 1991
- Chronic Hepatitis BNew England Journal of Medicine, 1990
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis BGastroenterology, 1988
- Survival in Chronic Hepatitis BAnnals of Internal Medicine, 1984